Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (330)	4/12/2002 9:18:32 AM
From: scaram(o)uche	Respond to of 1336

>> I had a thought about nibbling some glfd the other day << I did. :-(

To: Mike McFarland who wrote (330)	4/12/2002 10:24:41 AM
From: Extra Pale	Read Replies (1) \| Respond to of 1336

ASCO leaks Message 17320992 Have read in the past how ASCO leaks are effectively exempt from SEC regs, which totally sucks from my 'outsider' perspective. Guess the strategy is to track ASCO leaks and short appropriately. Am concerned about gzmo action being related to ASCO tho it has suffered strong downward pressure for some time now.

To: Mike McFarland who wrote (330)	4/17/2002 10:45:42 AM
From: scaram(o)uche	Respond to of 1336

glfd...... at least it bounced back strong, a rational response to the phase II. and there is nil-A news today..... the question..... without AMGN, will these results be sufficient to attract a new partner??......... biz.yahoo.com I'm not committed to this view, but..... looks like biological activity.